- Home
- FRA vs TMCI Comparison
FRA vs TMCI Comparison
Compare FRA & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRA
- TMCI
- Stock Information
- Founded
- FRA 2003
- TMCI 2014
- Country
- FRA United States
- TMCI United States
- Employees
- FRA N/A
- TMCI N/A
- Industry
- FRA Investment Bankers/Brokers/Service
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FRA Finance
- TMCI Health Care
- Exchange
- FRA Nasdaq
- TMCI Nasdaq
- Market Cap
- FRA 449.1M
- TMCI 371.1M
- IPO Year
- FRA N/A
- TMCI 2021
- Fundamental
- Price
- FRA $12.87
- TMCI $5.53
- Analyst Decision
- FRA
- TMCI Hold
- Analyst Count
- FRA 0
- TMCI 6
- Target Price
- FRA N/A
- TMCI $9.18
- AVG Volume (30 Days)
- FRA 165.4K
- TMCI 352.4K
- Earning Date
- FRA 01-01-0001
- TMCI 08-05-2025
- Dividend Yield
- FRA 11.06%
- TMCI N/A
- EPS Growth
- FRA N/A
- TMCI N/A
- EPS
- FRA N/A
- TMCI N/A
- Revenue
- FRA N/A
- TMCI $210,819,000.00
- Revenue This Year
- FRA N/A
- TMCI $10.61
- Revenue Next Year
- FRA N/A
- TMCI $10.36
- P/E Ratio
- FRA N/A
- TMCI N/A
- Revenue Growth
- FRA N/A
- TMCI 7.54
- 52 Week Low
- FRA $11.33
- TMCI $4.54
- 52 Week High
- FRA $13.10
- TMCI $10.79
- Technical
- Relative Strength Index (RSI)
- FRA 56.56
- TMCI 34.86
- Support Level
- FRA $12.41
- TMCI $5.36
- Resistance Level
- FRA $12.96
- TMCI $6.28
- Average True Range (ATR)
- FRA 0.10
- TMCI 0.24
- MACD
- FRA -0.01
- TMCI -0.00
- Stochastic Oscillator
- FRA 60.00
- TMCI 16.30
About FRA Blackrock Floating Rate Income Strategies Fund Inc
Blackrock Floating Rate Inc Stra Fd Inc is a United States-based diversified closed-ended management investment company. The Fund's investment objective is to provide shareholders with high current income and preservation of capital with investment in a diversified, leveraged portfolio consisting of floating-rate debt securities and instruments.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.